Proactiveinvestors USA & Canada Canntab Therapeutics Ltd https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Canntab Therapeutics Ltd RSS feed en Tue, 09 Mar 2021 00:40:23 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Canntab Therapeutics says it has completed its second delivery of two additional SKU's ordered by MediPharm Labs https://www.proactiveinvestors.com/companies/news/942887/canntab-therapeutics-says-it-has-completed-its-second-delivery-of-twoadditional-sku-s-ordered-by-medipharm-labs-942887.html Wed, 03 Mar 2021 15:30:00 -0500 https://www.proactiveinvestors.com/companies/news/942887/canntab-therapeutics-says-it-has-completed-its-second-delivery-of-twoadditional-sku-s-ordered-by-medipharm-labs-942887.html Canntab Therapeutics aims to deliver more precise, easy-to-take THC and CBD via its pills https://www.proactiveinvestors.com/companies/news/224815/canntab-therapeutics-aims-to-deliver-more-precise-easy-to-take-thc-and-cbd-via-its-pills-224815.html Tue, 02 Feb 2021 11:30:00 -0500 https://www.proactiveinvestors.com/companies/news/224815/canntab-therapeutics-aims-to-deliver-more-precise-easy-to-take-thc-and-cbd-via-its-pills-224815.html Canntab Therapeutics granted patent for their hard pill proprietary cannabidiol formulations https://www.proactiveinvestors.com/companies/news/940052/canntab-therapeutics-granted-patent-for-their-hard-pill-proprietary-cannabidiol-formulations-940052.html Mon, 01 Feb 2021 18:42:00 -0500 https://www.proactiveinvestors.com/companies/news/940052/canntab-therapeutics-granted-patent-for-their-hard-pill-proprietary-cannabidiol-formulations-940052.html Canntab Therapeutics granted Canadian patent for its hard pill cannabidiol formulations https://www.proactiveinvestors.com/companies/news/940031/canntab-therapeutics-granted-canadian-patent-for-its-hard-pill-cannabidiol-formulations-940031.html Mon, 01 Feb 2021 15:10:00 -0500 https://www.proactiveinvestors.com/companies/news/940031/canntab-therapeutics-granted-canadian-patent-for-its-hard-pill-cannabidiol-formulations-940031.html Canntab Therapeutics closes C$1.575 million non-brokered private placement of convertible debentures https://www.proactiveinvestors.com/companies/news/937537/canntab-therapeutics-closes-c1575-million-non-brokered-private-placement-of-convertible-debentures-937537.html Thu, 31 Dec 2020 19:07:00 -0500 https://www.proactiveinvestors.com/companies/news/937537/canntab-therapeutics-closes-c1575-million-non-brokered-private-placement-of-convertible-debentures-937537.html Canntab Therapeutics hits major milestone as company makes first delivery to MediPharm Labs https://www.proactiveinvestors.com/companies/news/935412/canntab-therapeutics-hits-major-milestone-as-company-makes-first-delivery-to-medipharm-labs-935412.html Tue, 01 Dec 2020 16:41:00 -0500 https://www.proactiveinvestors.com/companies/news/935412/canntab-therapeutics-hits-major-milestone-as-company-makes-first-delivery-to-medipharm-labs-935412.html Canntab Therapeutics received purchase order from Australia while also taking part in research study https://www.proactiveinvestors.com/companies/news/932411/canntab-therapeutics-received-purchase-order-from-australia-while-also-taking-part-in-research-study-932411.html Mon, 26 Oct 2020 18:44:00 -0400 https://www.proactiveinvestors.com/companies/news/932411/canntab-therapeutics-received-purchase-order-from-australia-while-also-taking-part-in-research-study-932411.html Canntab to launch in Australia and take part in the nation’s largest cannabis research study https://www.proactiveinvestors.com/companies/news/932368/canntab-to-launch-in-australia-and-take-part-in-the-nations-largest-cannabis-research-study-932368.html Mon, 26 Oct 2020 12:49:00 -0400 https://www.proactiveinvestors.com/companies/news/932368/canntab-to-launch-in-australia-and-take-part-in-the-nations-largest-cannabis-research-study-932368.html Canntab Therapeutics closes $1M purchase of cannabis-processing equipment and leasehold improvements from CMAX Technologies https://www.proactiveinvestors.com/companies/news/931908/canntab-therapeutics-closes-1m-purchase-of-cannabis-processing-equipment-and-leasehold-improvements-from-cmax-technologies-931908.html Tue, 20 Oct 2020 12:37:00 -0400 https://www.proactiveinvestors.com/companies/news/931908/canntab-therapeutics-closes-1m-purchase-of-cannabis-processing-equipment-and-leasehold-improvements-from-cmax-technologies-931908.html Canntab Therapeutics achieves major milestone receiving first U.S. patent for multilayer tablets https://www.proactiveinvestors.com/companies/news/929595/canntab-therapeutics-achieves-major-milestone-receiving-first-us-patent-for-multilayer-tablets-929595.html Mon, 21 Sep 2020 17:01:00 -0400 https://www.proactiveinvestors.com/companies/news/929595/canntab-therapeutics-achieves-major-milestone-receiving-first-us-patent-for-multilayer-tablets-929595.html Canntab Therapeutics wins its first US patent covering its multi-layer tablet cannabinoid formulations https://www.proactiveinvestors.com/companies/news/929587/canntab-therapeutics-wins-its-first-us-patent-covering-its-multi-layer-tablet-cannabinoid-formulations-929587.html Mon, 21 Sep 2020 15:55:00 -0400 https://www.proactiveinvestors.com/companies/news/929587/canntab-therapeutics-wins-its-first-us-patent-covering-its-multi-layer-tablet-cannabinoid-formulations-929587.html Canntab Therapeutics spends C$1.3M on cannabis processing equipment in two all-stock deals https://www.proactiveinvestors.com/companies/news/927290/canntab-therapeutics-spends-c13m-on-cannabis-processing-equipment-in-two-all-stock-deals-927290.html Fri, 21 Aug 2020 14:10:00 -0400 https://www.proactiveinvestors.com/companies/news/927290/canntab-therapeutics-spends-c13m-on-cannabis-processing-equipment-in-two-all-stock-deals-927290.html Canntab Therapeutics announces the appointment of Larry Latowsky as its CEO with immediate effect https://www.proactiveinvestors.com/companies/news/927049/canntab-therapeutics-announces-the-appointment-of-larry-latowsky-as-its-ceo-with-immediate-effect-927049.html Wed, 19 Aug 2020 12:20:00 -0400 https://www.proactiveinvestors.com/companies/news/927049/canntab-therapeutics-announces-the-appointment-of-larry-latowsky-as-its-ceo-with-immediate-effect-927049.html Canntab Therapeutics gets first commercial sale with Medipharm https://www.proactiveinvestors.com/companies/news/920975/canntab-therapeutics-gets-first-commercial-sale-with-medipharm-920975.html Tue, 02 Jun 2020 18:03:00 -0400 https://www.proactiveinvestors.com/companies/news/920975/canntab-therapeutics-gets-first-commercial-sale-with-medipharm-920975.html Canntab Therapeutics eyeing sales of its hard pills this summer as it strikes purchase deal with MediPharm Labs https://www.proactiveinvestors.com/companies/news/920965/canntab-therapeutics-eyeing-sales-of-its-hard-pills-this-summer-as-it-strikes-purchase-deal-with-medipharm-labs-920965.html Tue, 02 Jun 2020 16:05:00 -0400 https://www.proactiveinvestors.com/companies/news/920965/canntab-therapeutics-eyeing-sales-of-its-hard-pills-this-summer-as-it-strikes-purchase-deal-with-medipharm-labs-920965.html Canntab Therapeutics appoints pharmaceutical scientist as new CSO https://www.proactiveinvestors.com/companies/news/919722/canntab-therapeutics-appoints-pharmaceutical-scientist-as-new-cso-919722.html Fri, 15 May 2020 13:09:00 -0400 https://www.proactiveinvestors.com/companies/news/919722/canntab-therapeutics-appoints-pharmaceutical-scientist-as-new-cso-919722.html Canntab Therapeutics secures final tranche of C$3.7M private placement https://www.proactiveinvestors.com/companies/news/915027/canntab-therapeutics-secures-final-tranche-of-c37m-private-placement-915027.html Mon, 16 Mar 2020 13:15:00 -0400 https://www.proactiveinvestors.com/companies/news/915027/canntab-therapeutics-secures-final-tranche-of-c37m-private-placement-915027.html Canntab Therapeutics nominates Canadian pharmaceutical executive Larry Latowsky as executive chairman https://www.proactiveinvestors.com/companies/news/914498/canntab-therapeutics-nominates-canadian-pharmaceutical-executive-larry-latowsky-as-executive-chairman-914498.html Fri, 06 Mar 2020 14:27:00 -0500 https://www.proactiveinvestors.com/companies/news/914498/canntab-therapeutics-nominates-canadian-pharmaceutical-executive-larry-latowsky-as-executive-chairman-914498.html Canntab Therapeutics raised 3 million dollars and receives final Health Canada Licence https://www.proactiveinvestors.com/companies/news/914244/canntab-therapeutics-raised-3-million-dollars-and-receives-final-health-canada-licence-914244.html Tue, 03 Mar 2020 19:45:00 -0500 https://www.proactiveinvestors.com/companies/news/914244/canntab-therapeutics-raised-3-million-dollars-and-receives-final-health-canada-licence-914244.html Canntab Therapeutics awarded processing and sales license from Health Canada https://www.proactiveinvestors.com/companies/news/914086/canntab-therapeutics-awarded-processing-and-sales-license-from-health-canada-914086.html Mon, 02 Mar 2020 19:09:00 -0500 https://www.proactiveinvestors.com/companies/news/914086/canntab-therapeutics-awarded-processing-and-sales-license-from-health-canada-914086.html Canntab Therapeutics granted cannabis research licence from Health Canada https://www.proactiveinvestors.com/companies/news/913570/canntab-therapeutics-granted-cannabis-research-licence-from-health-canada-913570.html Mon, 24 Feb 2020 21:37:00 -0500 https://www.proactiveinvestors.com/companies/news/913570/canntab-therapeutics-granted-cannabis-research-licence-from-health-canada-913570.html Canntab awarded Health Canada cannabis research licence https://www.proactiveinvestors.com/companies/news/913553/canntab-awarded-health-canada-cannabis-research-licence-913553.html Mon, 24 Feb 2020 15:23:00 -0500 https://www.proactiveinvestors.com/companies/news/913553/canntab-awarded-health-canada-cannabis-research-licence-913553.html Canntab Therapeutics announces plans to raise C$2.5 million to fund expansion efforts https://www.proactiveinvestors.com/companies/news/912375/canntab-therapeutics-announces-plans-to-raise-c25-million-to-fund-expansion-efforts-912375.html Thu, 06 Feb 2020 20:17:00 -0500 https://www.proactiveinvestors.com/companies/news/912375/canntab-therapeutics-announces-plans-to-raise-c25-million-to-fund-expansion-efforts-912375.html Canntab Therapeutics submits Site Evidence Package to Health Canada for Licence Producer Status approval https://www.proactiveinvestors.com/companies/news/909737/canntab-therapeutics-submits-site-evidence-package-to-health-canada-for-licence-producer-status-approval-909737.html Mon, 23 Dec 2019 12:25:00 -0500 https://www.proactiveinvestors.com/companies/news/909737/canntab-therapeutics-submits-site-evidence-package-to-health-canada-for-licence-producer-status-approval-909737.html Exactus and Canntab team up to produce and sell hemp-derived cannabinoid tablets https://www.proactiveinvestors.com/companies/news/907494/exactus-and-canntab-team-up-to-produce-and-sell-hemp-derived-cannabinoid-tablets-907494.html Wed, 20 Nov 2019 17:59:00 -0500 https://www.proactiveinvestors.com/companies/news/907494/exactus-and-canntab-team-up-to-produce-and-sell-hemp-derived-cannabinoid-tablets-907494.html Canntab Therapeutics sign supply and distribution agreement with Exactus in U.S. https://www.proactiveinvestors.com/companies/news/907493/canntab-therapeutics-sign-supply-and-distribution-agreement-with-exactus-in-us-907493.html Wed, 20 Nov 2019 17:57:00 -0500 https://www.proactiveinvestors.com/companies/news/907493/canntab-therapeutics-sign-supply-and-distribution-agreement-with-exactus-in-us-907493.html Canntab sign deal with World Class Extractions to use the “Boss” machine https://www.proactiveinvestors.com/companies/news/904603/canntab-sign-deal-with-world-class-extractions-to-use-the-boss-machine-904603.html Thu, 10 Oct 2019 15:55:00 -0400 https://www.proactiveinvestors.com/companies/news/904603/canntab-sign-deal-with-world-class-extractions-to-use-the-boss-machine-904603.html Buds & Duds: Market conditions worsen for cannabis companies but Canntab Therapeutics soars on new joint venture agreement https://www.proactiveinvestors.com/companies/news/904413/buds--duds-market-conditions-worsen-for-cannabis-companies-but-canntab-therapeutics-soars-on-new-joint-venture-agreement-904413.html Tue, 08 Oct 2019 18:37:00 -0400 https://www.proactiveinvestors.com/companies/news/904413/buds--duds-market-conditions-worsen-for-cannabis-companies-but-canntab-therapeutics-soars-on-new-joint-venture-agreement-904413.html Buds & Duds: Market conditions worsen for cannabis companies but Canntab Therapeutics soars on new joint venture agreement https://www.proactiveinvestors.com/companies/news/904406/buds--duds-market-conditions-worsen-for-cannabis-companies-but-canntab-therapeutics-soars-on-new-joint-venture-agreement-904406.html Tue, 08 Oct 2019 15:30:00 -0400 https://www.proactiveinvestors.com/companies/news/904406/buds--duds-market-conditions-worsen-for-cannabis-companies-but-canntab-therapeutics-soars-on-new-joint-venture-agreement-904406.html Canntab Therapeutics teams up with World Class Extractions to process and manufacture CBD pills https://www.proactiveinvestors.com/companies/news/904390/canntab-therapeutics-teams-up-with-world-class-extractions-to-process-and-manufacture-cbd-pills-904390.html Tue, 08 Oct 2019 14:30:00 -0400 https://www.proactiveinvestors.com/companies/news/904390/canntab-therapeutics-teams-up-with-world-class-extractions-to-process-and-manufacture-cbd-pills-904390.html